We curate evidence from registries, peer-reviewed literature, official safety advisories, and primary reports. Our approach emphasizes transparency about sources and uncertainty: when the literature disagrees or when causal attribution is ambiguous, we state that plainly and show the underlying evidence. This is why we link to authoritative registries and summaries rather than relying solely on promotional or anecdotal material; for procedural context we sometimes point readers to clinical registries and explanatory pages such as the overview on ibogaine on Wikipedia to orient historical and pharmacologic claims.
We also present practical organizational notes: content is divided by topic pages (causes, mechanisms, risk factors, and case summaries) so readers can navigate from high-level explanations to detailed case-pattern reviews. When appropriate we include in-text links to reputable treatment directories so readers can compare reported offerings; for example, comparative listings like ibogaine treatment centers Canada are cited when location-based availability is discussed.